Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Louisiana Funds is an early-stage venture capital organization based in Louisiana, established to fill the financing gap for high technology companies in the state. The firm targets investments in sectors like life sciences, biotechnology, and agritechnology, with a focus on opportunities arising from local research universities. It currently manages a portfolio of seven companies.
This firm invests in early-stage companies developing commercially promising technologies, particularly those originating from Louisiana universities. Sectors of interest include life sciences, pharmaceuticals, biotechnology, and information technology. Louisiana Funds aims to provide right-sized investments to innovators to help build successful companies.
Notable companies in Louisiana Funds' portfolio include Precisis, which develops an implantable treatment for chronic epilepsy; Oncolytic Cancer Therapeutics, focused on innovative cancer treatments; and Mezzo, offering micro-tube heat exchanger technology. Other portfolio companies include Cardiac Catheter Technology, Active Battery Management, Aortic Valve Repair Implant, and Calosyn, which develops therapeutic drugs for osteoarthritis.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.